Data as of Sep 29
| +0.13 / +2.40%|
The 5 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 19.00, with a high estimate of 60.00 and a low estimate of 16.00. The median estimate represents a +242.34% increase from the last price of 5.55.
The current consensus among 5 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.